Medical Conference Schedule Sept. 2013 through March 2014

Viking Therapeutics Expands Obesity Pipeline With VK3019 Phase 1
Source: Streetwise Reports (06/27/2026)

Viking Therapeutics launches Phase 1 trial for VK3019 amylin agonist. Discover how this dual-receptor candidate fits the company's expanding obesity strategy and upcoming catalysts for investors.

read more >

uniQure Epilepsy Gene Therapy Data Draws Investor Focus
Source: Streetwise Reports (06/26/2026)

uniQure reports early AMT-260 results for refractory MTLE. See the trial data, pipeline catalysts, analyst price target, and what retail investors should watch next.

read more >

DarioHealth: Chronic Care Platform Drives Value
Source: Streetwise Reports (06/23/2026)

DarioHealth targets the booming digital health market with a multi-condition platform backed by 27 ADA studies. See pipeline growth, analyst targets, and key catalysts for investors.

read more >

Grey Matters Health Inc. Advances US Alzheimer's Clinics
Source: Streetwise Reports (06/23/2026)

Grey Matters Health Inc. closes CA$1.25M financing to launch brain-specific PET clinics targeting the expanding Alzheimer's diagnostics market and early detection demand.

read more >

Traws Pharma Positions Long-Acting Antivirals for Influenza and Outbreak Threats as Sector Opportunities Expand
Source: Streetwise Reports (06/20/2026)

Explore Traws Pharma's strategy in respiratory antivirals, cash runway to 2027, pipeline backups, and analyst perspectives amid evolving biopharma funding and flu market needs for retail investors.

read more >